Global viral vectors and plasmid dna manufacturing market research report 2017 by QYResearchReport

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017 By Players, Type and Applications, Status and Forecast, 2012-2022

Published by QYResearch Dec 2017

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Hard Copy: 2900 USD PDF Copy (single user): 2900 USD Enterprise wide License: 5800 USD Pages: 141 Tables and Figures: 149 Published Date: Dec 2017 Publisher: QYR Pharma & Healthcare Research Center Contact: Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com Summary This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries. In the last several years, global market of Viral Vectors and Plasmid DNA Manufacturing developed rapidly, with an average growth rate of 28.05%. In 2016, global revenue of Viral Vectors and Plasmid DNA Manufacturing is nearly 250 M USD. The major players in global Viral Vectors and Plasmid DNA Manufacturing market include BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics Richter-Helm FUJIFILM Diosynth Biotechnologies Lonza Aldevron Eurogentec Cell and Gene Therapy Catapult Biovian Brammer Bio VGXI PlasmidFactory Boehringer Ingelheim Geographically, this report is segmented into several key Regions, with revenue, Market Share and

Growth Rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2012 to 2022 (forecast), covering North America Europe Asia-Pacific South America Middle East and Africa On the basis of product, the Viral Vectors and Plasmid DNA Manufacturing market is primarily split into Plasmid DNA Viral Vectors

On the basis on the end users/applications, this report covers Cancers Inherited Disorders Viral Infections Other

Table of Contents 1 Viral Vectors and Plasmid DNA Manufacturing Market Overview................................................ 1 1.1 Viral Vectors and Plasmid DNA Manufacturing Product Overview.................................... 1 1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types (Product Category)....1 1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Comparison by Types (2012-2022).................................................................................... 1 1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016.....................................................................................................................................2 1.2.3 Viral Vectors...............................................................................................................2 1.2.4 Plasmid DNA............................................................................................................. 3 1.3 Global Viral Vectors and Plasmid DNA Manufacturing Segment by Applications.............3 1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Applications (2012-2022)................................................................................................... 3 1.3.2 Cancers.......................................................................................................................4 1.3.3 Inherited Disorders.....................................................................................................5 1.3.4 Viral Infections...........................................................................................................6 1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions (2012-2022). 7 1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Comparison by Regions (2012-2022).................................................................................7 1.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022).........................................................................................................................8 1.4.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022).........................................................................................................................9 1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022).......................................................................................................................10 1.4.5 South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022).......................................................................................................................11 1.4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)........................................................................................................12 1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2012-2022)...........13 2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers/Brand........................................................................................................................ 14 2.1 Global Viral Vectors Manufacturing Revenue and Share by Manufacturers (2016-2017)14 2.2 Global Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2016-2017) ................................................................................................................................................... 16 2.3 Global Viral Vectors and Plasmid DNA Manufacturing Gross Margin by Manufacturers (2016-2017)...............................................................................................................................18 2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters, Established Date, Product Types.................................................................................................................. 20 2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends ................................................................................................................................................... 22 2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate........ 22 2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5

Manufacturers................................................................................................................... 23 2.5.3 Mergers & Acquisitions, Expansion........................................................................ 24 3 Global Viral Vectors and Plasmid DNA Manufacturing, Revenue by Regions (2012-2017).......25 3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions (2012-2017).................................................................................................................25 3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)....................................................................................................... 26 3.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)........................................................................................ 26 3.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)....................................................................................................... 27 3.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017).................................................................................................27 3.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)........................................................................................ 28 3.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)............................................................................. 28 4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Growth Trend by Types........ 29 4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Types (2012-2017).................................................................................................................... 29 4.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)....31 5 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications......... 32 5.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Applications (2012-2017)......................................................................................................... 32 5.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)......................................................................................................... 34 6 Analysis of Viral Vectors and Plasmid DNA Manufacturing Industry Key Manufacturers......... 36 6.1 BioReliance.........................................................................................................................36 6.1.1 Company Profile...................................................................................................... 36 6.1.2 Product Information.................................................................................................37 6.1.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 37 6.2 Cobra Biologics...................................................................................................................37 6.2.1 Company Profile...................................................................................................... 37 6.2.2 Product Information.................................................................................................38 6.2.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 38 6.3 Oxford BioMedica.............................................................................................................. 38 6.3.1 Company Profile...................................................................................................... 38 6.3.2 Product Information.................................................................................................39 6.3.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 39 6.4 UniQure...............................................................................................................................40 6.4.1 Company Profile...................................................................................................... 40 6.4.2 Product Information.................................................................................................40 6.4.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 40 6.5 FinVector............................................................................................................................. 41

6.5.1 Company Profile...................................................................................................... 41 6.5.2 Product Information.................................................................................................41 6.5.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 42 6.6 MolMed...............................................................................................................................42 6.6.1 Company Profile...................................................................................................... 42 6.6.2 Product Information.................................................................................................43 6.6.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 43 6.7 MassBiologics.....................................................................................................................43 6.7.1 Company Profile...................................................................................................... 43 6.7.2 Product Information.................................................................................................44 6.7.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 44 6.8 Richter-Helm.......................................................................................................................44 6.8.1 Company Profile...................................................................................................... 44 6.8.2 Product Information.................................................................................................45 6.8.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 45 6.9 FUJIFILM Diosynth Biotechnologies................................................................................ 46 6.9.1 Company Profile...................................................................................................... 46 6.9.2 Product Information.................................................................................................46 6.9.3 Revenue, Cost, Gross Profit and Gross Margin...................................................... 47 6.10 Lonza.................................................................................................................................47 6.10.1 Company Profile.................................................................................................... 47 6.10.2 Product Information...............................................................................................48 6.10.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 48 6.11 Aldevron............................................................................................................................ 48 6.11.1 Company Profile.................................................................................................... 48 6.11.2 Product Information............................................................................................... 49 6.11.3 Revenue, Cost, Gross Profit and Gross Margin.....................................................49 6.12 Eurogentec........................................................................................................................ 50 6.12.1 Company Profile.................................................................................................... 50 6.12.2 Product Information...............................................................................................50 6.12.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 51 6.13 Cell and Gene Therapy Catapult.......................................................................................51 6.13.1 Company Profile.................................................................................................... 51 6.13.2 Product Information...............................................................................................52 6.13.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 52 6.14 Biovian.............................................................................................................................. 52 6.14.1 Company Profile.................................................................................................... 52 6.14.2 Product Information...............................................................................................53 6.14.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 53 6.15 Brammer Bio.....................................................................................................................53 6.15.1 Company Profile.................................................................................................... 53 6.15.2 Product Information...............................................................................................54 6.15.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 54 6.16 VGXI.................................................................................................................................55

6.16.1 Company Profile.................................................................................................... 55 6.16.2 Product Information...............................................................................................55 6.16.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 56 6.17 PlasmidFactory..................................................................................................................56 6.17.1 Company Profile.................................................................................................... 56 6.17.2 Product Information...............................................................................................57 6.17.3 Revenue, Cost, Gross Profit and Gross Margin.................................................... 57 7 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis........................... 59 7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis................. 59 7.1.1 Key Raw Materials.................................................................................................. 59 7.1.2 Key Suppliers of Raw Materials..............................................................................60 7.2 Proportion of Manufacturing Cost Structure...................................................................... 60 7.2.1 Raw Materials.......................................................................................................... 61 7.2.2 Labor Cost Analysis.................................................................................................61 7.2.2.1 USA Labor Cost Analysis............................................................................... 61 7.2.2.2 Europe Labor Costs Analysis.........................................错误！未定义书签。 7.2.2.3 Asia Labor Costs Analysis............................................. 错误！未定义书签。 7.2.3 Other Costs Analysis................................................................................................61 7.2.3.1 USA Cost of Electricity Analysis.................................... 错误！未定义书签。 7.2.3.2 USA Water Cost Analysis.............................................. 错误！未定义书签。 7.2.3.3 Europe Cost of Electricity Analysis............................... 错误！未定义书签。 7.2.3.4 Europe Water Cost Analysis......................................... 错误！未定义书签。 7.2.3.5 China Cost of Electricity Analysis................................. 错误！未定义书签。 7.2.3.6 China Water Cost Analysis............................................错误！未定义书签。 7.2.4 Manufacturing Expenses......................................................... 错误！未定义书签。 7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing.......61 8 Industrial Chain, Sourcing Strategy and Downstream Buyers......................................................62 8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis...................... 62 8.2 Upstream Raw Materials Sourcing.....................................................................................62 8.3 Downstream Buyers............................................................................................................62 9 Marketing Strategy Analysis, Distributors/Traders....................................................................... 63 9.1 Marketing Channel..............................................................................................................63 9.1.1 Direct Marketing......................................................................................................63 9.1.2 Indirect Marketing................................................................................................... 63 9.1.3 Marketing Channel Development Trend................................................................. 63 9.2 Market Positioning..............................................................................................................63 9.2.1 Pricing Strategy........................................................................................................63 9.2.2 Brand Strategy......................................................................................................... 63 9.2.3 Target Client.............................................................................................................63 10 Market Effect Factors Analysis....................................................................................................64 10.1 Technology Progress in Related Industry......................................................................... 64 10.2 Consumer Needs/Customer Preference Change...............................................................64 10.3 Economic/Political Environmental Change......................................................................64 11 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)............. 65

11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)65 11.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Regions (2017-2022)...............................................................................................................................66 11.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022).......................................................................................................................67 11.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing and Revenue Forecast (2017-2022).......................................................................................................................68 11.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022).......................................................................................................................69 11.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022).......................................................................................................................70 11.2.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)........................................................................................................ 71 11.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2017-2022)...............................................................................................................................71 11.4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2017-2022)...............................................................................................................................72 12 Research Findings and Conclusion..............................................................................................74 13 Methodology and Data Source.....................................................................................................75 13.1 Methodology/Research Approach.................................................................................... 75 13.1.1 Research Programs/Design.................................................................................... 75 13.1.2 Market Size Estimation..........................................................................................76 13.1.3 Market Breakdown and Data Triangulation.......................................................... 77 13.2 Data Source....................................................................................................................... 78 13.2.1 Secondary Sources.................................................................................................78 13.2.2 Primary Sources..................................................................................................... 79 13.3 Disclaimer......................................................................................................................... 80 13.4 Author List........................................................................................................................ 81

List of Tables and Figures Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing...............................1 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2012-2022)............................................1 Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016.....................................................................................................................................2 Figure Product Picture of Viral Vectors...................................................................................... 2 Figure Product Picture of Plasmid DNA.................................................................................... 3 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Applications (2012-2022).............................................................................................. 3 Figure Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Applications in 2016........................................................................................................... 3 Figure Cancers Examples........................................................................................................... 4 Figure Inherited Disorders Examples......................................................................................... 5 Figure Viral Infections Examples............................................................................................... 6 Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Comparison and Growth by Regions (2012-2022)............................................................ 7 Table Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Regions 2012-2022................................................................................... 7 Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)................................................................................................... 8 Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)................................................................................................... 9 Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022).................................................................................................10 Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)................................................................................................. 11 Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)................................................................................12 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Status and Outlook (2012-2022)........................................................................................................ 13 Table Global Viral Vectors Revenue (M USD) of Key Manufacturers (2016-2017)...............14 Table Global Viral Vectors Manufacturing Revenue Share by Manufacturers (2016-2017)...14 Figure 2016 Viral Vectors Manufacturing Revenue Share by Manufacturers......................... 15 Figure 2017 Viral Vectors Manufacturing Revenue Share by Manufacturers......................... 16 Table Global Plasmid DNA Manufacturing Revenue (M USD) by Manufacturers (2016-2017) ...........................................................................................................................................16 Table Global Plasmid DNA Manufacturing Revenue Share by Manufacturers (2016-2017). 17 Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers................................................................................................................... 17 Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers................................................................................................................... 18 Table Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key

Manufacturers (2016-2017).............................................................................................. 18 Figure Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers in 2016...................................................................................................... 19 Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters and Established Date................................................................................................................20 Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Product Category.......20 Figure Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate.............. 22 Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Manufacturers ...........................................................................................................................................23 Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Manufacturers ...........................................................................................................................................24 Table Mergers & Acquisitions, Expansion...............................................错误！未定义书签。 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Regions (2012-2017).......................................................................................................................25 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)........................................................................................................ 25 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017)........................................................................................................ 26 Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions.........................................................................................................................26 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017).............................................. 26 Table North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)..........................26 Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017).................................... 27 Table Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017).................................... 27 Table South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017)..........................28 Table Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017).............. 28 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Types (2012-2017).......................................................................................................................29 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Types (2012-2017).......................................................................................................................29 Figure Revenue Share of Viral Vectors and Plasmid DNA Manufacturing by Types (2012-2017).......................................................................................................................30 Figure 2016 Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Types................................................................................................................................. 30 Figure Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017) ...........................................................................................................................................31 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Applications (2012-2017)................................................................................................. 32

Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)................................................................................................. 32 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)................................................................................................. 33 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications in 2016......................................................................................................... 33 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)................................................................................................. 34 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)................................................................................................. 34 Table BioReliance Company Profile........................................................................................ 36 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of BioReliance 2016-2017.............................37 Table Cobra Biologics Company Profile.................................................................................. 37 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cobra Biologics. 38 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cobra Biologics 2016-2017.......................38 Table Oxford BioMedica Company Profile..............................................................................38 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Oxford BioMedica ...........................................................................................................................................39 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Oxford BioMedica 2016-2017.................. 39 Table UniQure Company Profile.............................................................................................. 40 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UniQure 2016-2017...................................40 Table FinVector Company Profile............................................................................................ 41 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FinVector............41 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FinVector 2016-2017................................. 42 Table MolMed Company Profile.............................................................................................. 42 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of MolMed............. 43 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MolMed 2016-2017...................................43 Table MassBiologics Company Profile.................................................................................... 43 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MassBiologics 2016-2017.........................44 Table Richter-Helm Company Profile...................................................................................... 44 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Richter-Helm..... 45 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Richter-Helm 2016-2017...........................45 Table FUJIFILM Diosynth Biotechnologies Company Profile................................................46 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FUJIFILM Diosynth Biotechnologies.................................................................................................46 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD),

Gross Profit (M USD) and Gross Margin of FUJIFILM Diosynth Biotechnologies 2016-2017......................................................................................................................... 47 Table Lonza Company Profile.................................................................................................. 47 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Lonza................. 48 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Lonza 2016-2017.......................................48 Table Aldevron Company Profile............................................................................................. 48 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Aldevron.............49 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Aldevron 2016-2017..................................49 Table Eurogentec Company Profile.......................................................................................... 50 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Eurogentec......... 50 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Eurogentec 2016-2017.............................. 51 Table Cell and Gene Therapy Catapult Company Profile........................................................ 51 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cell and Gene Therapy Catapult...............................................................................................................52 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cell and Gene Therapy Catapult 2016-2017 ...........................................................................................................................................52 Table Biovian Company Profile................................................................................................52 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Biovian...............53 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Biovian 2016-2017.................................... 53 Table Brammer Bio Company Profile...................................................................................... 53 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Brammer Bio..... 54 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Brammer Bio 2016-2017...........................54 Table VGXI Company Profile.................................................................................................. 55 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of VGXI..................55 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of VGXI 2016-2017.......................................56 Table PlasmidFactory Company Profile................................................................................... 56 Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of PlasmidFactory.. 57 Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of PlasmidFactory 2016-2017........................57 Table Key Raw Materials of Viral Vectors and Plasmid DNA Manufacturing........................59 Table Key Suppliers of Raw Materials..................................................................................... 60 Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing..... 60 Figure USA Labor Cost Analysis 2012-2016...........................................错误！未定义书签。 Figure Cost of Employing a Factory Worker........................................... 错误！未定义书签。 Figure 2016 Estimated Labour Costs for the Whole Economy in Europe错误！未定义书签。 Figure Monthly Minimum Wages in Asia 2016.......................................错误！未定义书签。 Figure China Labor Costs 2013-2016...................................................... 错误！未定义书签。

Table Average Price of Electricity to Ultimate Customers 2007-2016....错误！未定义书签。 Figure Electricity Prices for Household Consumers in 2016...................错误！未定义书签。 Figure Summary of the Driving Assumptions......................................... 错误！未定义书签。 Figure Industrial Electric Rates 2016 (PER KWH)................................. 错误！未定义书签。 Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing. 61 Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis.................62 Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing.................................62 Figure Setting Pricing Policy................................................................... 错误！未定义书签。 Figure Global GDP Growth Rate for 2016.............................................. 错误！未定义书签。 Figure US GDP 2006-2016 (Billion USD).............................................. 错误！未定义书签。 Figure US CPI Change 2016-2017...........................................................错误！未定义书签。 Figure EU GDP 2006-2016 (Billion USD).............................................. 错误！未定义书签。 Figure EU CPI Change 2012-2016.......................................................... 错误！未定义书签。 Figure Germany GDP 2006-2016 (Billion USD).................................... 错误！未定义书签。 Figure Germany CPI Change 2016-2017.................................................错误！未定义书签。 Figure UK GDP 2006-2016 (Billion USD)..............................................错误！未定义书签。 Figure UK CPI Change 2016-2017.......................................................... 错误！未定义书签。 Figure Italy GDP 2006-2016 (Billion USD)............................................ 错误！未定义书签。 Figure Italy CPI Change 2016-2017........................................................ 错误！未定义书签。 Figure Japan GDP 2006-2016 (Billion USD).......................................... 错误！未定义书签。 Figure Japan CPI Change 2012-2016.......................................................错误！未定义书签。 Figure China GDP 2006-2016 (Billion USD)..........................................错误！未定义书签。 Figure China CPI Change 2016-2017...................................................... 错误！未定义书签。 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022).................................................................................. 65 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Regions (2017-2022)........................................................................................................ 66 Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Regions (2017-2022)........................................................................................................ 66 Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022).................................................................................. 67 Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022).................................................................................. 68 Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022).................................................................................. 69 Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022).................................................................................. 70 Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)................................................................. 71 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Type (2017-2022)..............................................................................................................71 Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Type (2017-2022).......................................................................................... 72 Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by

Application (2017-2022)...................................................................................................72 Figure Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application (2017-2022).......................................................................................................................73

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1 Viral Vectors and Plasmid DNA Manufacturing Market Overview 1.1 Viral Vectors and Plasmid DNA Manufacturing Product Overview This report is about the market of viral vectors and plasmid DNA manufacturing products. The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.

Figure Product Picture of Viral Vectors and Plasmid DNA Manufacturing

Source: Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types (Product Category) 1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Comparison by Types (2012-2022) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2012-2022) 2012

2016

2022

Market Share (%)2022

CGAR (%) (2016-2022)

Viral Vectors Plasmid DNA Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016 Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016 Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

1.2.3 Viral Vectors Figure Product Picture of Viral Vectors

Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.2.4 Plasmid DNA Figure Product Picture of Plasmid DNA

Source: QYR Pharma & Healthcare Research Center, Dec 2017

1.3

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Segment by Applications 1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Applications (2012-2022) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Applications (2012-2022) 2012

2016

2022

Market Share (%)2022

CGAR (%) (2016-2022)

Cancers Inherited Disorders Viral Infections Others Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Applications in 2016

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

1.3.2 Cancers Figure Cancers Examples

Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.3.3 Inherited Disorders Figure Inherited Disorders Examples

Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.3.4 Viral Infections Figure Viral Infections Examples

Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.4

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Market by Regions (2012-2022) 1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market

Size

and

Growth

Comparison

Regions

(2012-2022) Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Comparison and Growth by Regions (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Table Global Market Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Comparison by Regions 2012-2022 2012

2016

2022

Market Share (%)2022

CAGR (2016-2022)

North America Europe Asia-Pacific South America Middle East and Africa Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

1.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022) Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.4.3

Asia-Pacific

Viral

Vectors

and

Plasmid

DNA

Manufacturing Status and Prospect (2012-2022) Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022) Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.4.5 South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022) Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022) Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

1.5

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Market Size (2012-2022) Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Status and Outlook (2012-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers/Brand 2.1 Global Viral Vectors Manufacturing Revenue and Share by Manufacturers (2016-2017) Table Global Viral Vectors Revenue (M USD) of Key Manufacturers (2016-2017) 2016

2017

BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics FUJIFILM Diosynth Biotechnologies Lonza Cell and Gene Therapy Catapult Biovian Brammer Bio Other Total Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Table Global Viral Vectors Manufacturing Revenue Share by Manufacturers (2016-2017) 2016

2017

BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

MassBiologics FUJIFILM Diosynth Biotechnologies Lonza Cell and Gene Therapy Catapult Biovian Brammer Bio Other Total Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Figure 2016 Viral Vectors Manufacturing Revenue Share by Manufacturers

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure 2017 Viral Vectors Manufacturing Revenue Share by Manufacturers

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

2.2 Global Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2016-2017) Table Global Plasmid DNA Manufacturing Revenue (M USD) by Manufacturers (2016-2017) 2016

2017

Cobra Biologics Boehringer Ingelheim Richter-Helm Aldevron Eurogentec VGXI PlasmidFactory Other Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Total Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Table Global Plasmid DNA Manufacturing Revenue Share by Manufacturers (2016-2017) 2016

2017

Cobra Biologics Boehringer Ingelheim Richter-Helm Aldevron Eurogentec VGXI PlasmidFactory Other Total Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure 2017 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

2.3

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Gross Margin by Manufacturers (2016-2017) Table Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers (2016-2017) 2016

2017

BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics Richter-Helm

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

FUJIFILM Diosynth Biotechnologies Lonza Aldevron Eurogentec Cell and Gene Therapy Catapult Biovian Brammer Bio VGXI PlasmidFactory Boehringer Ingelheim Other Average Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Figure Global Market Viral Vectors and Plasmid DNA Manufacturing Gross Margin of Key Manufacturers in 2016

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Pharma & Healthcare Research Center, Dec 2017

2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing

Headquarters,

Established

Date,

Product Types Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters and Established Date Headquarters

Established Date

Source: Above companies; QYR Pharma & Healthcare Research Center, Dec 2017

Table Manufacturers Viral Vectors and Plasmid DNA Manufacturing Product Category Product Category

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Above companies; QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends 2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate Figure Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 Manufacturers

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 5 Manufacturers

Source: Above companies; Secondary Sources, Press Releases, Expert Interviews and QYR Pharma & Healthcare Research Center, Dec 2017

2.5.3 Mergers & Acquisitions, Expansion

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

3 Global Viral Vectors and Plasmid DNA Manufacturing, Revenue by Regions (2012-2017) 3.1

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Revenue and Market Share by Regions (2012-2017) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Regions (2012-2017) 2012

2013

2014

2015

2016

2017

North America Europe Asia-Pacific South America Middle East and Africa Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017) 2012

2013

2014

2015

2016

2017

North America Europe Asia-Pacific South America Middle East and Africa Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions (2012-2017) Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Figure 2016 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Regions Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

3.2

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017) 2012

2013

2014

2015

2016

2017

Revenue (M USD) Gross Profit (M USD) Cost (M USD) Gross Margin Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

3.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017) Table North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017) 2012

2013

2014

2015

2016

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

2017 26

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Revenue (M USD) Gross Profit (M USD) Cost (M USD) Gross Margin Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

3.4

Europe

Viral

Vectors

and

Plasmid

DNA

Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017) Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017) 2012

2013

2014

2015

2016

2017

Revenue (M USD) Gross Profit (M USD) Cost (M USD) Gross Margin Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

3.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017) Table Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017) 2012

2013

2014

2015

2016

2017

Revenue (M USD) Gross Profit (M USD) Cost (M USD) Gross Margin Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

3.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017) Table South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017) 2012

2013

2014

2015

2016

2017

Revenue (M USD) Gross Profit (M USD) Cost (M USD) Gross Margin Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

3.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017) Table Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Gross Profit (M USD), Cost (M USD) and Gross Margin (2012-2017) 2012

2013

2014

2015

2016

2017

Revenue (M USD) Gross Profit (M USD) Cost (M USD) Gross Margin Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Growth Trend by Types 4.1

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Revenue and Market Share by Types (2012-2017) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Types (2012-2017) 2012

2013

2014

2015

2016

2017

Viral Vectors Plasmid DNA Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Types (2012-2017) 2012

2013

2014

2015

2016

2017

Viral Vectors Plasmid DNA Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Revenue Share of Viral Vectors and Plasmid DNA Manufacturing by Types (2012-2017)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Figure 2016 Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Types

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

4.2

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Growth by Type (2012-2017) Figure Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017) Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

5 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications 5.1

Global

Viral

Vectors

and

Plasmid

DNA

Manufacturing Revenue and Market Share by Applications (2012-2017) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) by Applications (2012-2017) 2012

2013

2014

2015

2016

2017

Cancers Inherited Disorders Viral Infections Others Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017) 2012

2013

2014

2015

2016

2017

Cancers Inherited Disorders Viral Infections Others Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications (2012-2017)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Applications in 2016

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

5.2

Global

Viral

Manufacturing

Vectors

Revenue

and

Plasmid

Growth

DNA

Rate

Applications (2012-2017) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017) 2012

2013

2014

2015

2016

2017

Cancers Inherited Disorders Viral Infections Others Average Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

5.3 Global Plasmid DNA Revenue Market Share by Application in 2016 Global Plasmid DNA Revenue Market Share by Application in 2016

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6 Analysis of Viral Vectors and Plasmid DNA Manufacturing Industry Key Manufacturers 6.1 BioReliance 6.1.1 Company Profile Table BioReliance Company Profile

Source: BioReliance, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.1.2 Product Information 6.1.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of BioReliance 2016-2017

Source: BioReliance, QYR Pharma & Healthcare Research Center, Dec 2017

6.2 Cobra Biologics 6.2.1 Company Profile Table Cobra Biologics Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Cobra Biologics, QYR Pharma & Healthcare Research Center, Dec 2017

6.2.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cobra Biologics Source: Cobra Biologics, QYR Pharma & Healthcare Research Center, Dec 2017

6.2.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cobra Biologics 2016-2017

Source: Cobra Biologics, QYR Pharma & Healthcare Research Center, Dec 2017

6.3 Oxford BioMedica 6.3.1 Company Profile Table Oxford BioMedica Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Oxford BioMedica, QYR Pharma & Healthcare Research Center, Dec 2017

6.3.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Oxford BioMedica Source: Oxford BioMedica, QYR Pharma & Healthcare Research Center, Dec 2017

6.3.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Oxford BioMedica 2016-2017

Source: Oxford BioMedica, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.4 UniQure 6.4.1 Company Profile Table UniQure Company Profile

Source: UniQure, QYR Pharma & Healthcare Research Center, Dec 2017

6.4.2 Product Information

6.4.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UniQure 2016-2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: UniQure, QYR Pharma & Healthcare Research Center, Dec 2017

6.5 FinVector 6.5.1 Company Profile Table FinVector Company Profile

Source: FinVector, QYR Pharma & Healthcare Research Center, Dec 2017

6.5.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FinVector

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: FinVector, QYR Pharma & Healthcare Research Center, Dec 2017

6.5.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FinVector 2016-2017

Source: FinVector, QYR Pharma & Healthcare Research Center, Dec 2017

6.6 MolMed 6.6.1 Company Profile Table MolMed Company Profile

Source: MolMed, QYR Pharma & Healthcare Research Center, Dec 2017 Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.6.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of MolMed Source: MolMed, QYR Pharma & Healthcare Research Center, Dec 2017

6.6.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MolMed 2016-2017

Source: MolMed, QYR Pharma & Healthcare Research Center, Dec 2017

6.7 MassBiologics 6.7.1 Company Profile Table MassBiologics Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: MassBiologics, QYR Pharma & Healthcare Research Center, Dec 2017

6.7.2 Product Information

6.7.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of MassBiologics 2016-2017

Source: MassBiologics, QYR Pharma & Healthcare Research Center, Dec 2017

6.8 Richter-Helm 6.8.1 Company Profile Table Richter-Helm Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Richter-Helm, QYR Pharma & Healthcare Research Center, Dec 2017

6.8.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Richter-Helm Source: Richter-Helm, QYR Pharma & Healthcare Research Center, Dec 2017

6.8.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Richter-Helm 2016-2017

Source: Richter-Helm, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.9 FUJIFILM Diosynth Biotechnologies 6.9.1 Company Profile Table FUJIFILM Diosynth Biotechnologies Company Profile

Source: FUJIFILM Diosynth Biotechnologies, QYR Pharma & Healthcare Research Center, Dec 2017

6.9.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of FUJIFILM Diosynth Biotechnologies Source: FUJIFILM Diosynth Biotechnologies, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.9.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of FUJIFILM Diosynth Biotechnologies 2016-2017

Source: FUJIFILM Diosynth Biotechnologies, QYR Pharma & Healthcare Research Center, Dec 2017

6.10 Lonza 6.10.1 Company Profile Table Lonza Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Lonza, QYR Pharma & Healthcare Research Center, Dec 2017

6.10.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Lonza Source: Lonza, QYR Pharma & Healthcare Research Center, Dec 2017

6.10.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Lonza 2016-2017

Source: Lonza, QYR Pharma & Healthcare Research Center, Dec 2017

6.11 Aldevron 6.11.1 Company Profile Table Aldevron Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Aldevron, QYR Pharma & Healthcare Research Center, Dec 2017

6.11.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Aldevron Source: Aldevron, QYR Pharma & Healthcare Research Center, Dec 2017

6.11.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Aldevron 2016-2017

Source: Aldevron, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.12 Eurogentec 6.12.1 Company Profile Table Eurogentec Company Profile

Source: Eurogentec, QYR Pharma & Healthcare Research Center, Dec 2017

6.12.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Eurogentec Source: Eurogentec, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.12.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Eurogentec 2016-2017

Source: Eurogentec, QYR Pharma & Healthcare Research Center, Dec 2017

6.13 Cell and Gene Therapy Catapult 6.13.1 Company Profile Table Cell and Gene Therapy Catapult Company Profile

Source: Cell and Gene Therapy Catapult, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.13.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Cell and Gene Therapy Catapult Source: Cell and Gene Therapy Catapult, QYR Pharma & Healthcare Research Center, Dec 2017

6.13.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Cell and Gene Therapy Catapult 2016-2017

Source: Cell and Gene Therapy Catapult, QYR Pharma & Healthcare Research Center, Dec 2017

6.14 Biovian 6.14.1 Company Profile Table Biovian Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Biovian, QYR Pharma & Healthcare Research Center, Dec 2017

6.14.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Biovian Source: Biovian, QYR Pharma & Healthcare Research Center, Dec 2017

6.14.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Biovian 2016-2017

Source: Biovian, QYR Pharma & Healthcare Research Center, Dec 2017

6.15 Brammer Bio 6.15.1 Company Profile Table Brammer Bio Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Brammer Bio, QYR Pharma & Healthcare Research Center, Dec 2017

6.15.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of Brammer Bio Source: Brammer Bio, QYR Pharma & Healthcare Research Center, Dec 2017

6.15.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost 2016

2017

Revenue (M USD)

2.14

2.67

Gross Profit (M USD)

0.69

0.92

Cost (M USD)

1.45

1.75

Gross Margin

32.46%

34.41%

Source: Brammer Bio, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.16 VGXI 6.16.1 Company Profile Table VGXI Company Profile

Source: VGXI, QYR Pharma & Healthcare Research Center, Dec 2017

6.16.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of VGXI Source: VGXI, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.16.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of VGXI 2016-2017

Source: VGXI, QYR Pharma & Healthcare Research Center, Dec 2017

6.17 PlasmidFactory 6.17.1 Company Profile Table PlasmidFactory Company Profile

Source: PlasmidFactory, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

6.17.2 Product Information Figure Viral Vectors and Plasmid DNA Manufacturing Product Picture of PlasmidFactory Source: PlasmidFactory, QYR Pharma & Healthcare Research Center, Dec 2017

6.17.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of PlasmidFactory 2016-2017

Source: PlasmidFactory, QYR Pharma & Healthcare Research Center, Dec 2017

6.18 Boehringer Ingelheim 6.18.1 Company Profile Table Boehringer Ingelheim Company Profile

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Source: Boehringer Ingelheim, QYR Pharma & Healthcare Research Center, Dec 2017

6.18.2 Product Information 6.18.3 Revenue, Cost, Gross Profit and Gross Margin Table Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Boehringer Ingelheim 2016-2017

Source: Boehringer Ingelheim, QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

7 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis 7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis 7.1.1 Key Raw Materials Table Key Raw Materials of Viral Vectors and Plasmid DNA Manufacturing

Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

7.1.2 Key Suppliers of Raw Materials Table Key Suppliers of Raw Materials

Source: Above Companies; QYR Pharma & Healthcare Research Center, Dec 2017

7.2 Proportion of Manufacturing Cost Structure Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing

Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

7.2.1 Raw Materials The raw materials include the direct material, like raw materials, accessory material and packing materials.

7.2.2 Labor Cost Analysis 7.2.2.1 USA Labor Cost Analysis

7.2.3 Other Costs Analysis

7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing Source: QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis Source: QYR Pharma & Healthcare Research Center, Dec 2017

8.2 Upstream Raw Materials Sourcing 8.3 Downstream Buyers Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing Source: Above companies and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client .

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

10 Market Effect Factors Analysis 10.1 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022) 11.1

Global Viral Vectors and

Plasmid

DNA

Manufacturing Revenue Forecast (2017-2022) Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11.2

Global Viral Vectors and

Manufacturing

Revenue

Plasmid

Forecast

DNA

Regions

(2017-2022) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Regions (2017-2022) 2017

2018

2019

2020

2021

2022

North America Europe Asia-Pacific South America Middle East and Africa Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Share Forecast by Regions (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022) Figure North America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11.2.2

Europe

Viral

Vectors

and

Plasmid

DNA

Manufacturing and Revenue Forecast (2017-2022) Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11.2.3 Asia-Pacific Viral Vectors

and

Plasmid

DNA

Manufacturing Revenue Forecast (2017-2022) Figure Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022) Figure South America Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

11.2.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022) Figure Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) and Growth Rate Forecast (2017-2022)

Source: Experts Interview and QYR Pharma & Healthcare Research Center, Dec 2017

11.3

Global Viral Vectors and

Manufacturing

Revenue

Plasmid

Forecast

DNA Type

(2017-2022) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Type (2017-2022) 2017

2018

2019

2020

2021

2022

Viral Vectors Plasmid DNA Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share Forecast by Type (2017-2022)

Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

11.4

Global Viral Vectors and

Plasmid

DNA

Manufacturing Revenue Forecast by Application (2017-2022) Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue (M USD) Forecast by Application (2017-2022) 2017

2018

2019

2020

2021

2022

Cancers Inherited Disorders Viral Infections Others Total Source: Experts Interview, Secondary Sources and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application (2017-2022)

Source: Experts Interview and QYR Pharma & Healthcare Research Center, Dec 2017

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

12 Research Findings and Conclusion After several months of survey and research, research group obtains the following conclusions:

This is the end of Viral Vectors and Plasmid DNA Manufacturing report. Thanks for reading, for any question, please feel free to contact the QYR Pharma & Healthcare Research Center Center analyst Mr. Zhang Dong, 0086-10-82945717 0086-13811796901 sales@qyresearch.com

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

13 Methodology and Data Source 13.1 Methodology/Research Approach This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

13.1.1 Research Programs/Design Table Research Programs/Design for This Report Research Design

Historical Data (2012-2016)

Influencing Factors

Market Forecast (2017-2022)

Industry Trends

Global Revenue ; Status and Outlook;

Competitive Landscape By Manufacturers; Expansion; Mergers and Acquisitions

Product Revenue for Top Players Market Share Growth Rate Present Situation Analysis;

Market Segment By Types By Applications By Regions/ Geography

Revenue Market Share; Growth Rate Present Situation Analysis

Market Environment Government Policy Technological Changes

Market Drivers Growing Demand of Downstream Reduction in Cost

Market Risks

Market Opportunities and Challenges

Market Size Forecast Global Overall Size By Type/Product Category By Applications/End Users By Regions/Geography

Key Data (Revenue) Market Size; Market Share; Growth Rate ; Growth; Product

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

13.1.2 Market Size Estimation Top-down and bottom-up approaches are used to validate the global Viral Vectors and Plasmid DNA Manufacturing market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). The market estimations in this report are based on the marketed sale price of Viral Vectors and Plasmid DNA Manufacturing (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). The percentage splits, Market Share (%)s, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Viral Vectors and Plasmid DNA Manufacturing market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country. Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share (%)s, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources. All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report. The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Figure Bottom-up and Top-down Approaches for This Report Total Global Market Size

Share of Companies’ Revenue in Each Product Segment

Market Share Splits by Type; Regions Uptake of the Market, by End Users/ Application

Company-wise Revenue in the Global Market

Regional and Country-wise Market for Each subsegment

Bottom-up Approach:

Top-down Approach:

Market data information Collection and analysis, through Primary Sources and Secondary Sources;

Global Market Size is validated through Primary Sources and Secondary Sources;

Primary Sources:  Demand-side Experts  Supply-side Experts Secondary Sources:  Annual Reports  Presentations  Press Releases  Journals  Paid Databases  QYResearch Repository

13.1.3 Market Breakdown and Data Triangulation After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report. Secondary Sources Annual Reports Presentations Press Releases Journals Paid Databases QYR Research

Supply Side

Interviews With: Manufacturers Distributor Opinion Leaders Industry Experts Front-line Staff Directors CEO Marketing Executives Technology and Innovation Directors Executives from Related Industries and Organizations Interviews With: Purchasing/Product Managers End Users/Buyers Industry Experts Opinion Leaders Research Institutes

TRADING ECONOMICS Federal Reserve Economic Data Bloomberg Business Hoovers Factiva

Source

Primary Sources

Demand Side

Figure Data Triangulation

Key Manufacturers

Market Analysis by Product Category

Market Forecast

Competitive Landscape

Market Analysis by Regions

Market Estimates

Market Share Growth Rate

and

Market Analysis /Applications

End

Users Risks, Opportunities and Challenges

13.2 Data Source 13.2.1 Secondary Sources Secondary Sources such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Viral Vectors and Plasmid DNA Manufacturing market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Table Key Data Information from Secondary Sources Parameters

Key Data

Market Size

Segmental Revenue

Market Position of Top Players Qualitative Analysis

Sources

Journals, Websites, and Press Releases Geographic Penetration Product Adoption Rate For Different Annual Reports and SEC Filings Company Websites and Press End Users Releases Product Financials Public and Paid Databases Geographic Revenue Mix QYR Pharma & Healthcare Research Total Company Revenue Center Data Repository Business/Segmental Revenue Mix Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies

Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations QYR Pharma & Healthcare Research Center Data Repository

13.2.2 Primary Sources In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market. Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Table Key Data Information from Primary Sources Primary Sources

Parameters

Key Data Revenue and Market Share of Product Types

By Product Types

Revenue by Product Types, Status and Outlook

By Applications (End Users)

Value by Applications/End Users, Status and Outlook

Value in Major Applications

Market Segments by Regions

Revenue by Regions, Status and Outlook (2012-2022)

Revenue, Growth Rate Market Share by Regions

Global Market

Global Overall Size Global Market Size Status and (Revenue), Present Situation Forecast (2012-2022) and Forecast

Market Segments

Revenue and Growth Rate of Product Types

Percentage and Growth Rate of Each Application and

13.3 Disclaimer The information and opinions in this report were prepared by QYR Pharma & Healthcare Research Center. The information herein is believed to be reliable and has been obtained from authentic public sources. QYR Pharma & Healthcare Research Center research and analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that QYR Pharma & Healthcare Research Center research and analysis services are for our customersâ&#x20AC;&#x2122; internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. QYR Pharma & Healthcare Research Center does not endorse any vendors, product or service depicted in their research publications. QYR Pharma & Healthcare Research Center research and analysis publications consist of the opinions of QYR Pharma & Healthcare Research Centerâ&#x20AC;&#x2122;s research and should not be construed as statements of fact. QYR Pharma & Healthcare Research Center disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. QYResearch takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher are prohibited.

13.4 Author List First Analyst

Second Analyst

Sample Pages Canary canary@qyresearch.com +86-15810099726

Invoice Accounting Finance Lin Laisheng ssgotg@qyresearch.com +86-13710213452

Dispatch Quality Research etc Tan Xiaohu tanxiaohu@qyresearch.com +86-13718936094

Xiang Yongfei xiangyongfei@qyresearch.com +86-15650765230

Business or New Require Zhang Dong sales@qyresearch.com +86-13811796901 24H Phone or Email Service(Asia Europe US) China Beijing Time info@qyresearch.com +86-1082945717

US California Time aftersale@qyresearch.com +1-6262952442

Tel: 86-20-22093278/ 86-18813753184; Email: sales@qyresearchglobal.com; www.qyresearch.com